Medpace (MEDP) was Initiated by Jefferies to “Hold”. Jefferies advised their investors in a research report released on Sep 6, 2016.
Many Wall Street Analysts have commented on Medpace. Robert W. Baird Initiated Medpace on Sep 6, 2016 to “Neutral”, Price Target of the shares are set at $35.
In a different news, on Aug 19, 2016, August J. Troendle (CEO) purchased 10,000 shares at $27.98 per share price. According to the SEC, on Aug 18, 2016, Susan E Burwig (Sr. Vice President, Operations) purchased 19,211 shares at $29.25 per share price.